Tolterodine Tartrate 00093-7164-05
- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Capsule, Extended Release
- Product Type
- Drug For Further Processing
- Marketing Start
- October 20, 2020
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tolterodine Tartrate | 4 mg/1 |
Packaging Options(1)
16129 CAPSULE, EXTENDED RELEASE in 1 CONTAINER (0093-7164-99)